EMR vs OTIS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 23, 2026

EMR

69.7
AI Score
VS
EMR Wins

OTIS

28.8
AI Score

Investment Advisor Scores

EMR

70score
Recommendation
STRONG BUY

OTIS

29score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR OTIS Winner
Forward P/E 20.8333 15.1515 OTIS
PEG Ratio 1.728 2.2268 EMR
Revenue Growth 7.0% 7.3% OTIS
Earnings Growth 23.0% 13.0% EMR
Tradestie Score 69.7/100 28.8/100 EMR
Profit Margin 13.8% 10.2% EMR
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY SELL EMR

Relative Price Performance (Last 90 Days)

EMR 1M: +8.5% · 3M: +14.2% OTIS 1M: -9.6% · 3M: -12.8%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 63

RSI (14): 62.8 · Price: $161.61

OTIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 31

RSI (14): 31.0 · Price: $64.05

Fundamentals Snapshot

Metric EMR OTIS
Market Cap — —
Forward P/E 22.2 14.1
Trailing P/E 33.9 16.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.3% 0.2%
EPS 4.68 3.90
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.